| Trial ID: | L0368 |
| Source ID: | NCT00433342
|
| Associated Drug: |
Flucloxacillin
|
| Title: |
The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Flucloxacillin
|
| Outcome Measures: |
Primary: p-cresol reduction rate, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Universitaire Ziekenhuizen KU Leuven
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-03
|
| Completion Date: |
2020-04
|
| Results First Posted: |
|
| Last Update Posted: |
2020-04-27
|
| Locations: |
Universitaire Ziekenhuizen Leuven, Leuven, Vlaams-Brabant, 3000, Belgium
|
| URL: |
https://clinicaltrials.gov/show/NCT00433342
|
